Dr. Cano-Cano is a postdoctoral researcher with expertise in neurological and immunological processes with experience in peripheral immune cell analysis, particularly PBMCs, using advanced proteomic, molecular and cellular approaches to investigate inflammatory and neurodegenerative pathways. Her experience also includes the study of diabetes related complications, particularly diabetic retinopathy, using optical coherence tomography and retinal imaging, as well as the evaluation of bioactive compounds with anti-inflammatory potential in cellular and translational models.
In our lab, Dr. Cano-Cano is responsible for blood-based biomarkers and biological sample processing within our neuroimaging and psychophysiology research group. Their work focuses on identifying early markers of neurodegeneration and neuroinflammation across multiple neurological conditions, including Multiple Sclerosis, Parkinson’s disease, Alzheimer’s disease, and Ataxia. She specializes in the analysis of circulating biomarkers using ultra-sensitive technologies such as Sioma, complemented by ELISA and targeted proteomic approaches. Her research primarily investigates markers of neurological alterations, including NfL, GFAP, BDNF, sTREM, different Tau species, among others.
In addition, she contributes to the integration of blood-based biomarkers with neuroimaging, psychophysiological, and neurostimulation mesasures to characterize early disease-related alterations and monitor progression. Her work supports translational research efforts aimed at improving early detection, patient stratification, and the development of personalized therapeutic strategies in neurodegenerative and neuroinflammatory disorders.
